FORTH, Institute of Computer Science, Heraklion, Crete, Greece.
Europace. 2013 Jun;15 Suppl 1:i59-i64. doi: 10.1093/europace/eut110.
To provide a European perspective on reimbursement issues surrounding remote monitoring of cardiac implantable electronic devices in view of the anticipated costs and benefits.
Review of recent literature addressing clinical, economic, sociocultural, and technological factors associated with remote monitoring. When healthcare transformation is urgently needed, remote monitoring offers opportunities to innovate and cope with escalating costs and constrained resources, while improving patient safety, quality, and access to care as reflected in clinical studies. The introduction of remote monitoring into daily practice requires analysis of reimbursement policies to address funding scope, payment method, payer, price and allocation, and alignment with health system objectives and goals to ensure financial and operational sustainability of resources, infrastructure, and processes. Remote monitoring policies should gradually transition from activity-based, added-value services in a care-and-cure setting, to performance and outcome-oriented highlighting prevention, surveillance, and empowerment. By encouraging and rewarding innovation and interoperability, proprietary remote monitoring technologies can open up using standards and connect to support a growing evidence base that guides clinical decision support and planning of future policies.
Careful planning, sharing of experiences, and gradual adoption of reimbursement models that focus on outcome, performance, and cost-effectiveness are key aspects of containing escalating costs and improving quality and access to healthcare. Despite differences in health systems and payment methods in Europe, policy-makers, professional societies, payers, providers, and the industry need to join forces to transform healthcare and make innovation happen.
鉴于预期成本和收益，从欧洲角度探讨心脏植入式电子设备远程监测的报销问题。
对与远程监测相关的临床、经济、社会文化和技术因素的最新文献进行综述。当迫切需要医疗保健转型时，远程监测提供了创新和应对成本不断上升和资源受限的机会，同时提高了患者安全、质量和获得医疗服务的机会，这在临床研究中得到了体现。引入远程监测到日常实践中需要分析报销政策，以解决资金范围、支付方式、付款人、价格和分配问题，并与卫生系统的目标和目的保持一致，以确保资源、基础设施和流程的财务和运营可持续性。远程监测政策应逐步从以活动为基础、以治疗为重点的附加价值服务向注重预防、监测和授权的绩效和结果导向转变。通过鼓励和奖励创新和互操作性，专有的远程监测技术可以采用标准并连接起来，以支持不断增长的证据基础，为临床决策支持和未来政策规划提供指导。
精心规划、分享经验并逐步采用注重结果、绩效和成本效益的报销模式是控制成本上升、提高医疗质量和可及性的关键方面。尽管欧洲的卫生系统和支付方式存在差异，但政策制定者、专业协会、付款人、提供者和行业需要联合起来，推动医疗保健转型并实现创新。
